López-Munoz, F. and álamo, C. (2011) Neurobiological background for the development of new drugs in schizophrenia. Clinical Neuropharmacology, 34, 111-126. doi:10.1097/WNF.0b013e318215c2f7
has been cited by the following article:
Related Articles: